Item 9 Financials
INLB Stock | USD 0.0001 0.00 0.00% |
Item |
Understanding current and past Item 9 Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Item 9's financial statements are interrelated, with each one affecting the others. For example, an increase in Item 9's assets may result in an increase in income on the income statement.
Please note, the presentation of Item 9's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Item 9's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Item 9's management manipulating its earnings.
Item 9 Stock Summary
Item 9 competes with Grey Cloak. Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 103 people.Instrument | USA Pink Sheet View All |
Exchange | PINK Exchange |
ISIN | US46564C2035 |
Business Address | 2727 North 3rd |
Sector | Pharmaceuticals |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.item9labscorp.com |
Phone | 833 867 6337 |
Currency | USD - US Dollar |
Item 9 Key Financial Ratios
Item 9's financial ratios allow both analysts and investors to convert raw data from Item 9's financial statements into concise, actionable information that can be used to evaluate the performance of Item 9 over time and compare it to other companies across industries.Return On Equity | -0.42 | |||
Return On Asset | -0.0721 | |||
Target Price | 4.0 | |||
Number Of Employees | 97 | |||
Beta | 0.77 |
Item Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Item 9's current stock value. Our valuation model uses many indicators to compare Item 9 value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Item 9 competition to find correlations between indicators driving Item 9's intrinsic value. More Info.Item 9 Labs is rated second overall in return on equity category among its peers. It is currently regarded as number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Item 9 by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Item 9's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Item 9 Labs Systematic Risk
Item 9's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Item 9 volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Item 9 Labs correlated with the market. If Beta is less than 0 Item 9 generally moves in the opposite direction as compared to the market. If Item 9 Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Item 9 Labs is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Item 9 is generally in the same direction as the market. If Beta > 1 Item 9 moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for Item Pink Sheet analysis
When running Item 9's price analysis, check to measure Item 9's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Item 9 is operating at the current time. Most of Item 9's value examination focuses on studying past and present price action to predict the probability of Item 9's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Item 9's price. Additionally, you may evaluate how the addition of Item 9 to your portfolios can decrease your overall portfolio volatility.
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |